U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
ODRONEXTAMAB
8R5CM46UIO
Investigational
General
Names
11
Classification
2
Identifiers
6
Subunits
4
Related Substances
1
ODRONEXTAMAB
8R5CM46UIO
Investigational
General
Approval Year
Unknown
149,124
Names
11
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
REGN-1979
Preferred Name
English
ODRONEXTAMAB
Official Name
English
ANTI-CD20/CD3 MONOCLONAL ANTIBODY REGN1979
Common Name
English
IMMUNOGLOBULIN G4-KAPPA ANTI-(HOMO SAPIENS B-LYMPHOCYTE ANTIGEN CD20), HETERO DIMER WITH IMMUNOGLOBULIN G4-KAPPA ANTI-(HOMO SAPIENS T-CELL SURFACE GLYCOPROTEIN CD3 EPSILON CHAIN) HUMAN MONOCLONAL ANTIBODY .GAMMA.4 HEAVY CHAIN (1-453) (HOMO SAPIENS VH (IG
Common Name
English
ANTI-CD20 X ANTI-CD3 BISPECIFIC MONOCLONAL ANTIBODY REGN1979
Common Name
English
Showing 1 to 5 of 11 entries
Previous
1
2
3
Next
Classification
2
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of follicular lymphoma
FDA ORPHAN DRUG
623317
Designated
ORPHAN DRUG
Designated
Treatment of diffuse large b-cell lymphoma.
FDA ORPHAN DRUG
569816
Showing 1 to 2 of 2 entries
Previous
1
Next
Identifiers
6
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
FDA UNII
8R5CM46UIO
PRIMARY
NCI_THESAURUS
C119615
PRIMARY
USAN
EF-150
PRIMARY
INN
11035
PRIMARY
SMS_ID
100000181452
PRIMARY
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
8R5CM46UIO
ODRONEXTAMAB